Oncology Venture Sweden AB

Oncology Venture AB was formed in 2012 by Danish and US oncology specialists and business people dedicated to unlock the potential of oncology products that has shown efficacy but not enough to beat the gold standard - to improve the efficacy of the drugs, increase the response rate in cancer patients, reduce timelines and through this improve success rates in Oncology Drug Development.

Quotes for Oncology Venture Sweden AB

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Peter Buhl Jensen

Chairperson of the Board

  • Duncan Moore

Board

  • Peter Birk Rasmussen
  • Sanjeevi Carani
  • Ulla Hald Buhl
  • Steen Knudsen
  • Duncan Moore

News

Show More

Videos

CEO Peter Buhl Jensens presentation of Oncolocy Venture Sweden AB at Sedermeradagen Copenhagen

VD Peter Buhl Jensen på Aktiesparardagen i Lund

VD Peter Buhl Jensen på Sedermeradagen i Stockholm

VD Peter Buhl Jensen presenterar bolaget på Sedermeradagen 2016

Annual reports, prospectus etc.